FC Barcelona is investing in cutting-edge medical science by analyzing players' epigenomes to assess their individual susceptibility to injuries. In partnership with the Clínic-IDIBAPS research center, the club studied 74 players to identify biological patterns linked to injury risks.
This research integrates physical and mental health data, including stress and lifestyle factors. Epigenetic modifications, such as DNA methylation patterns, serve as biomarkers reflecting current physical state and potential for injury.
Cases like those of Gavi and Marc Bernal highlighted the need for tailored recovery and prevention protocols. The club employs neuroscience insights and monitors athletes' psychological states to prevent injuries proactively.
Barcelona also embraces personalized medicine by considering genetic profiles to adapt training loads and rehabilitation plans. This approach accelerates recovery times and lowers the chances of recurring injuries.
These scientific advances underscore the increasing role of integrative, proactive medical care in professional football. For Barcelona, facing a packed match calendar and fierce competition, such innovations offer a strategic edge by keeping the squad fit and available throughout the season.
